Comparison of four cardiovascular risk prediction functions among Chinese patients with diabetes mellitus in the primary care setting

Journal of Diabetes Investigation

Volumn 5, Issue 5, 2014, Pages 606-614

  Jiao, Fang Fang ^a   Lam, Cindy Lo Kuen ^a   Fung, Colman ^a   Mcghee, Sarah Morag ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cardiovascular diseases; Diabetes complications; Risk

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BILE ACID SEQUESTRANT; FIBRIC ACID DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHINESE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CONVERGENT VALIDITY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE DURATION; EFFECT SIZE; FEASIBILITY STUDY; FEMALE; FRAMINGHAM RISK SCORE; GLOMERULUS FILTRATION RATE; HEALTH PROGRAM; HONG KONG; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTION; PREVALENCE; PRIMARY MEDICAL CARE; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SMOKING; UNITED KINGDOM PROSPECTIVE DIABETES STUDY;

EID: 84908601924     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12188     Document Type: Article

References (38)

1. International Diabetes Federation. Diabetes Atlas, 5rd edn http://www.idf.org/diabetesatlas/2012. Available from: http://www.idf.org/diabetesatlas/.
2. Shaw J, Sicree R, Zimmet P. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14.
3. Wong KC, Wang Z. Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Res Clin Pract 2006; 73: 126-134.
4. American Diabetes Association. Standards of medical care in diabetes 2012. Diabetes Care 2012; 35(Suppl 1): S11-S63.
5. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486-2497.
6. Chamnan P, Simmons RK, Sharp SJ, et al. Cardiovascular risk assessment scores for people with diabetes: a systematic review. Diabetologia 2009; 52: 2001-2014 (English).
7. Canadian Diabetes Association. 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32(Suppl 1): S1-S201.
8. American Diabetes Association. Standards of medical care in diabetes 2013. Diabetes Care 2013; 36(Suppl 1): S11-S66.
9. National Institute for Health and Clinical Excellence. Type 2 Diabetes National Clinical Guideline for Management in Primary and Secondary Care (Update). Royal College of Physicians, London, UK, 2008.
10. Clark CM, Snyder JW, Meek RL, et al. A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction. Diabetes Care 2001; 24: 1079-1086.
11. Ko GT, So WY, Tong PC, et al. From design to implementation-the Joint Asia Diabetes Evaluation (JADE) program: a descriptive report of an electronic web-based diabetes management program. BMC Med Inform Decis Mak 2010; 10: 26.
12. Task Force on Conceptual Model and Preventive Protocols Working Group on Primary Care. Food and Health Bureau. Hong Kong Reference Framework for Diabetes Care for Adults in Primary Care Settings, Hong Kong, 2010.
13. Khunti K, Ganguli S. Who looks after people with diabetes: primary or secondary care? J R Soc Med 2000; 93: 183-186.
14. Care WP. Chronic illness management: what is the role of primary care? Ann Intern Med 2003; 138: 256-261.
15. D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 743-753.
16. Stevens RJ, Kothari V, Adler AI, et al. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) 2001; 101: 671-679.
17. Wu YF, Liu XQ, Li X, et al. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation 2006; 114: 2217-2225.
18. Yang X, So WY, Kong AP, et al. klDevelopment and validation of a total coronary heart disease risk score in type 2 diabetes mellitus. Am J Cardiol 2008; 101: 596-601.
19. Liu J, Hong Y, D'Agostino RB Sr, et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 2004; 291: 2591-2599.
20. Barzi F, Patel A, Gu D, et al. Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health 2007; 61: 115-121.
21. Chien KL, Hsu HC, Su TC, et al. Constructing a point-based prediction model for the risk of coronary artery disease in a Chinese community: a report from a cohort study in Taiwan. Int J Cardiol 2012; 157: 263-268.
22. Kothari V, Stevens RJ, Adler AI, et al. UKPDS 60 risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 2002; 33: 1776-1781.
23. Yang X, So WY, Kong AP, et al. Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes Care 2007; 30: 65-70.
24. Fung CS, Chin WY, Dai DS, et al. Evaluation of the quality of care of a multi-disciplinary risk factor assessment and management programme (RAMP) for diabetic patients. BMC Fam Pract 2012; 13: 116.
25. Chan J, So W, Ko G, et al. The Joint Asia Diabetes Evaluation (JADE) Program: a web-based program to translate evidence to clinical practice in Type 2 diabetes. Diabet Med 2009; 26: 693-699.
26. Wilson PWF, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847 (English).
27. de Visser CL, Bilo HJG, Thomsen TF, et al. Prediction of coronary heart disease: a comparison between the Copenhagen risk score and the Framingham risk score applied to a Dutch population. J Intern Med 2003; 253: 553-562 (English).
28. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum Associaties, Inc, New Jersey, 1988.
29. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157.
30. Guzder RN, Gatling W, Mullee MA, et al. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study. Diabet Med 2005; 22: 554-562.
31. McEwan P, Williams JE, Griffiths JD, et al. Evaluating the performance of the Framingham risk equations in a population with diabetes. Diabet Med 2004; 21: 318-323.
32. Yeo W, Yeo KR. Predicting CHD risk in patients with diabetes mellitus. Diabet Med 2001; 18: 341-344.
33. Song SH, Brown PM. Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications. Diabet Med 2004; 21: 238-245.
34. Davis WA, Colagiuri S, Davis TM. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study. Med J Aust 2009; 190: 180.
35. Koskinen P, Manttari M, Manninen V, et al. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care 1992; 15: 820-825.
36. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998; 317: 703-713.
37. Wu HY, Wu LX, Zen QA, et al. Do currently recommended risk prediction tools help primary prevention of cardiovascular disease in Chinese population? Int J Cardiol 2011; 146: 299-301 (English).
38. International Diabetes Federation. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med 2006; 23: 579-593.